{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:08:37Z","timestamp":1790680117019,"version":"4.1.0"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T00:00:00Z","timestamp":1525910400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Inserm","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005736","name":"University Paris Diderot","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005736","id-type":"DOI","asserted-by":"crossref"}]},{"name":"ANR","award":["ToxME"],"award-info":[{"award-number":["ToxME"]}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0197249","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T17:40:36Z","timestamp":1525974036000},"page":"e0197249","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Insights into molecular mechanisms of drug metabolism dysfunction of human CYP2C9*30"],"prefix":"10.1371","volume":"13","author":[{"given":"Maxime","family":"Louet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line M.","family":"Labb\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3308-631X","authenticated-orcid":true,"given":"Charline","family":"Fagnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassiano M.","family":"Aono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Homem-de-Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno O.","family":"Villoutreix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6895-1214","authenticated-orcid":true,"given":"Maria A.","family":"Miteva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,5,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2133\/dmpk.DMPK-12-RV-085","article-title":"Impact of genetic polymorphisms in CYP2C9 and CYP2C19 on the pharmacokinetics of clinically used drugs","volume":"28","author":"T Hirota","year":"2013","journal-title":"Drug Metab Pharmacokinet"},{"issue":"1\u20132","key":"ref2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.drudis.2011.10.023","article-title":"Toward in silico structure-based ADMET prediction in drug discovery","volume":"17","author":"G Moroy","year":"2012","journal-title":"Drug Discov Today"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.drudis.2016.09.015","article-title":"Pharmacogenomics of the cytochrome P450 2C family: impacts of amino acid variations on drug metabolism","volume":"22","author":"A Isvoran","year":"2017","journal-title":"Drug Discov Today"},{"issue":"7","key":"ref4","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/00008571-200110000-00006","article-title":"Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid","volume":"11","author":"D Dai","year":"2001","journal-title":"Pharmacogenetics"},{"issue":"12","key":"ref5","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/FPC.0000000000000172","article-title":"Genetic variation in the human cytochrome P450 supergene family","volume":"25","author":"K Fujikura","year":"2015","journal-title":"Pharmacogenet Genomics"},{"issue":"7","key":"ref6","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2174\/138920009789895480","article-title":"Genetic polymorphism of the human cytochrome P450 2C9 gene and its clinical significance","volume":"10","author":"B Wang","year":"2009","journal-title":"Curr Drug Metab"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2133\/dmpk.DMPK-11-RV-090","article-title":"In vitro assessment of the allelic variants of cytochrome P450","volume":"27","author":"M Hiratsuka","year":"2012","journal-title":"Drug Metab Pharmacokinet"},{"issue":"21","key":"ref8","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1016\/j.jmb.2013.07.010","article-title":"Advances in molecular modeling of human cytochrome P450 polymorphism","volume":"425","author":"VY Martiny","year":"2013","journal-title":"J Mol Biol"},{"issue":"8","key":"ref9","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1291\/hypres.31.1549","article-title":"Genetic variations of CYP2C9 in 724 Japanese individuals and their impact on the antihypertensive effects of losartan","volume":"31","author":"T Yin","year":"2008","journal-title":"Hypertens Res"},{"issue":"7","key":"ref10","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/01.fpc.0000215069.14095.c6","article-title":"Four novel defective alleles and comprehensive haplotype analysis of CYP2C9 in Japanese","volume":"16","author":"K Maekawa","year":"2006","journal-title":"Pharmacogenet Genomics"},{"issue":"9","key":"ref11","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1124\/dmd.109.027003","article-title":"Substrate-dependent functional alterations of seven CYP2C9 variants found in Japanese subjects","volume":"37","author":"K Maekawa","year":"2009","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0003-9861(02)00548-9","article-title":"Substrate selectivity of human cytochrome P450 2C9: importance of residues 476, 365, and 114 in recognition of diclofenac and sulfaphenazole and in mechanism-based inactivation by tienilic acid","volume":"409","author":"A Melet","year":"2003","journal-title":"Arch Biochem Biophys"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"5476","DOI":"10.1021\/acs.biochem.7b00795","article-title":"Structural Basis of Single-Nucleotide Polymorphisms in Cytochrome P450 2C9","volume":"56","author":"K Maekawa","year":"2017","journal-title":"Biochemistry"},{"issue":"15","key":"ref14","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1002\/jcc.21568","article-title":"Mechanism of the decrease in catalytic activity of human cytochrome P450 2C9 polymorphic variants investigated by computational analysis","volume":"31","author":"E Sano","year":"2010","journal-title":"J Comput Chem"},{"issue":"40","key":"ref15","doi-asserted-by":"crossref","first-page":"8700","DOI":"10.1021\/bi100911q","article-title":"Intramolecular heme ligation of the cytochrome P450 2C9 R108H mutant demonstrates pronounced conformational flexibility of the B-C loop region: implications for substrate binding","volume":"49","author":"AG Roberts","year":"2010","journal-title":"Biochemistry"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/tpj.2013.41","article-title":"High warfarin sensitivity in carriers of CYP2C9*35 is determined by the impaired interaction with P450 oxidoreductase","volume":"14","author":"MY Lee","year":"2014","journal-title":"Pharmacogenomics J"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nchem.2474","article-title":"Discovery of a regioselectivity switch in nitrating P450s guided by molecular dynamics simulations and Markov models","volume":"8","author":"SC Dodani","year":"2016","journal-title":"Nat Chem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"7379","DOI":"10.1021\/jacs.5b02800","article-title":"Quantum mechanical\/molecular mechanical calculated reactivity networks reveal how cytochrome P450cam and Its T252A mutant select their oxidation pathways","volume":"137","author":"B Wang","year":"2015","journal-title":"J Am Chem Soc"},{"issue":"W1","key":"ref19","doi-asserted-by":"crossref","first-page":"W344","DOI":"10.1093\/nar\/gkw408","article-title":"ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules","volume":"44","author":"H Ashkenazy","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"ref20","first-page":"20","article-title":"Predicting functional effect of human missense mutations using PolyPhen-2","author":"I Adzhubei","year":"2013","journal-title":"Curr Protoc Hum Genet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1471-2105-12-151","article-title":"PoPMuSiC 2.1: a web server for the estimation of protein stability changes upon mutation and sequence optimality","volume":"12","author":"Y Dehouck","year":"2011","journal-title":"BMC Bioinformatics"},{"issue":"W1","key":"ref22","doi-asserted-by":"crossref","first-page":"W395","DOI":"10.1093\/nar\/gkv343","article-title":"ENCoM server: exploring protein conformational space and the effect of mutations on protein function and stability","volume":"43","author":"V Frappier","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"W382","DOI":"10.1093\/nar\/gki387","article-title":"The FoldX web server: an online force field","volume":"33","author":"J Schymkowitz","year":"2005","journal-title":"Nucleic Acids Res"},{"issue":"6006","key":"ref24","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1126\/science.1193478","article-title":"Cytochrome P450 compound I: capture, characterization, and C-H bond activation kinetics","volume":"330","author":"J Rittle","year":"2010","journal-title":"Science"},{"issue":"6947","key":"ref25","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature01862","article-title":"Crystal structure of human cytochrome P450 2C9 with bound warfarin","volume":"424","author":"PA Williams","year":"2003","journal-title":"Nature"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.bbagen.2006.07.005","article-title":"The ins and outs of cytochrome P450s","volume":"1770","author":"V Cojocaru","year":"2007","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"ref27","doi-asserted-by":"crossref","first-page":"e1002152","DOI":"10.1371\/journal.pcbi.1002152","article-title":"Structure and dynamics of the membrane-bound cytochrome P450 2C9","volume":"7","author":"V Cojocaru","year":"2011","journal-title":"PLoS Comput Biol"},{"issue":"34","key":"ref28","doi-asserted-by":"crossref","first-page":"35630","DOI":"10.1074\/jbc.M405427200","article-title":"The structure of human cytochrome P450 2C9 complexed with flurbiprofen at 2.0-A resolution","volume":"279","author":"MR Wester","year":"2004","journal-title":"J Biol Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.drudis.2014.03.012","article-title":"Structure-based ligand design to overcome CYP inhibition in drug discovery projects","volume":"19","author":"G Branden","year":"2014","journal-title":"Drug Discov Today"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"W372","DOI":"10.1093\/nar\/gki365","article-title":"PCE: web tools to compute protein continuum electrostatics","volume":"33","author":"MA Miteva","year":"2005","journal-title":"Nucleic Acids Res"},{"issue":"13","key":"ref31","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"EF Pettersen","year":"2004","journal-title":"J Comput Chem"},{"issue":"16","key":"ref32","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"GM Morris","year":"2009","journal-title":"J Comput Chem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"WL Jorgensen","year":"1983","journal-title":"The Journal of Chemical Physics"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1021\/ct300400x","article-title":"Optimization of the Additive CHARMM All-Atom Protein Force Field Targeting Improved Sampling of the Backbone \u03d5, \u03c8 and Side-Chain \u03c71 and \u03c72 Dihedral Angles","volume":"8","author":"RB Best","year":"2012","journal-title":"Journal of Chemical Theory and Computation"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM general force field: A force field for drug\u2010like molecules compatible with the CHARMM all\u2010atom additive biological force fields","volume":"31","author":"K Vanommeslaeghe","year":"2010","journal-title":"Journal of Computational Chemistry"},{"issue":"12","key":"ref36","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1021\/ci3003649","article-title":"Automation of the CHARMM General Force Field (CGenFF) II: assignment of bonded parameters and partial atomic charges","volume":"52","author":"K Vanommeslaeghe","year":"2012","journal-title":"J Chem Inf Model"},{"issue":"37","key":"ref37","doi-asserted-by":"crossref","first-page":"12900","DOI":"10.1021\/ja0520924","article-title":"Electronic structure of compound I in human isoforms of cytochrome P450 from QM\/MM modeling","volume":"127","author":"CM Bathelt","year":"2005","journal-title":"J Am Chem Soc"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/jcc.20289","article-title":"Scalable molecular dynamics with NAMD","volume":"26","author":"JC Phillips","year":"2005","journal-title":"Journal of Computational Chemistry"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: An N\u22c5log(N) method for Ewald sums in large systems","volume":"98","author":"T Darden","year":"1993","journal-title":"The Journal of Chemical Physics"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1063\/1.470648","article-title":"Constant pressure molecular dynamics simulation: The Langevin piston method","volume":"103","author":"SE Feller","year":"1995","journal-title":"The Journal of Chemical Physics"},{"issue":"11","key":"ref41","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1101\/gr.9.11.1106","article-title":"Exploring expression data: identification and analysis of coexpressed genes","volume":"9","author":"LJ Heyer","year":"1999","journal-title":"Genome Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"W Humphrey","year":"1996","journal-title":"Journal of Molecular Graphics"},{"issue":"24","key":"ref43","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1093\/bioinformatics\/btv486","article-title":"Integrated structure- and ligand-based in silico approach to predict inhibition of cytochrome P450 2D6","volume":"31","author":"VY Martiny","year":"2015","journal-title":"Bioinformatics"},{"issue":"17","key":"ref44","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.4155\/fmc.15.150","article-title":"Sampling of conformational ensemble for virtual screening using molecular dynamics simulations and normal mode analysis","volume":"7","author":"G Moroy","year":"2015","journal-title":"Future Med Chem"},{"issue":"14","key":"ref45","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated Docking Using a Lamarckian Genetic Algorithm and an Empirical Binding Free Energy Function","volume":"19","author":"GM Morris","year":"1998","journal-title":"Journal of Computational Chemistry"},{"issue":"10","key":"ref46","doi-asserted-by":"crossref","first-page":"e1002708","DOI":"10.1371\/journal.pcbi.1002708","article-title":"CAVER 3.0: a tool for the analysis of transport pathways in dynamic protein structures","volume":"8","author":"E Chovancova","year":"2012","journal-title":"PLoS Comput Biol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0197249","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T17:47:40Z","timestamp":1720288060000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0197249"}},"subtitle":[],"editor":[{"given":"Xuhui","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,5,10]]},"references-count":46,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0197249","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,10]]}}}